Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms. Academic Article uri icon

Overview

publication date

  • April 9, 2018

Identity

PubMed Central ID

  • PMC5908465

Scopus Document Identifier

  • 85044725167

Digital Object Identifier (DOI)

  • 10.1016/j.ccell.2018.03.024

PubMed ID

  • 29634952

Additional Document Info

volume

  • 33

issue

  • 4